Search News
| 38.12 Delayed Data As of 4:03pm ET |  +0.16 / +0.42%Today’s Change | 28.78 Today|||52-Week Range 39.76 | +9.86% Year-to-Date |
| Previous close | 37.96 |
| Today’s open | 38.29 |
| Day’s range | 38.07 - 38.38 |
| Volume | 8,235,454 |
| Average volume (3 months) | 3,905,456 |
| Market cap | $97.4B |
| Earnings growth (last year) | -13.30% |
| Earnings growth (this year) | -17.62% |
| Earnings growth (next 5 years) | +5.93% |
| Revenue growth (last year) | -1.03% |
| P/E ratio | 34.4 |
| Price/Sales | 3.87 |
| Price/Book | 6.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| AGNAllergan | +1.39 | +0.75% |
| LLYEli Lilly and Co | +1.19 | +1.14% |
| ABTAbbott Laboratories | +0.56 | +0.87% |
| NVONovo Nordisk | -0.31 | -0.65% |
| Next reporting date | November 8, 2018 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $22.7B |
| Annual profit (last year) | $3.0B |
| Net profit margin | 13.36% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Pascal Soriot |
Executive VP-Operations & Information Technology Pam P. Cheng |
Corporate headquarters Cambridge, Cambridgeshire |
